KCLAVIS Investment
Overview
KCLAVIS Investment is a Seoul-based venture capital firm specializing in early-stage investments in technology and biotech sectors. Founded in 2013, the firm focuses on providing funding and asset management services to technology-driven companies across South Korea and the United States. Their portfolio includes companies in biotechnology, health care, pharmaceutical, financial services, and information technology industries. The firm's investment strategy encompasses seed, early-stage, and late-stage ventures, with typical investment sizes ranging from $1 million to $5 million. KCLAVIS Investment has a history of leading investments and has been involved in 21 investments, with notable exits including Kasa and APR Corporation.
Investment Focus
- Technology-driven companies
- Early-stage ventures
- Biotech sectors
Portfolio Companies
Reach KCLAVIS Investment directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about KCLAVIS Investment
What sectors does KCLAVIS Investment invest in?
KCLAVIS Investment invests in Financial Services, Health Care, Information Technology, Biotechnology and Pharmaceutical, and is based in Seoul, South Korea. KCLAVIS Investment is listed as a venture capital in the ConnectSafely investor database.
What stage does KCLAVIS Investment invest at?
KCLAVIS Investment backs companies at Seed, Early Stage and Late Stage, writing cheques of 1M - 5M.
Which regions does KCLAVIS Investment invest in?
KCLAVIS Investment invests across United States and South Korea.
What companies has KCLAVIS Investment invested in?
KCLAVIS Investment's portfolio includes Kasa and APR Corporation.
Last updated · Source: ConnectSafely investor database
